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LETTER TO THE EDITORS
ASSOCIATION OF PROTEIN-LOSING ENTEROPATHY
CAUSED BY EOSINOPHILIC GASTROENTERITIS
WITH ESSENTIAL THROMBOCYTOSIS: CASE
REPORT
Márcio Silva Miguel Lima, Valdinélia dos Santos Bomfim, Audrey Zeinad, Bruno Ctenas, and Milton Hideaki Arai
Protein-losing enteropathy is not a single disease; it is
an atypical manifestation of other disease processes and is
marked by excessive loss of protein into the gastrointestinal
tract.1 These diseases can be classified into 3 large groups
according to the protein-loss mechanism: ulcerated lesions
with protein exudation (eg, peptic ulcer, inflammatory
bowel disease, and gastric carcinoma), mucosal lesions
without ulceration, but with increased permeability (eg,
Ménétrier’s disease, celiac sprue, and eosinophilic gastro-
enteritis), and obstructive diseases (eg, lymphoma), as well
as primary disorder of the lymphatic system (eg, intestinal
lymphangiectasia).
One of the several causes of protein-losing enteropa-
thy is eosinophilic gastroenteritis. This is a rare disease
characterized by infiltration of eosinophils from the mu-
cosa to the serosa layer, mainly in the stomach and the
small bowel.2–4 Eosinophilia and anemia are common
hematological manifestations, but platelet abnormalities
have not been reported.
Essential thrombocytosis is a rare myeloproliferative
disorder. High platelet count, which can be as high as more
than 1 million platelets/mm3 in peripheral blood, is the hall-
mark of this disorder. The disease can progress with throm-
botic and hemorrhagic episodes.5 Essential thrombocyto-
sis is not a cause of protein-losing enteropathy, and its as-
sociation with eosinophilic gastroenteritis has not been re-
ported.
We report a rare case of a concurrent manifestation of
eosinophilic gastroenteritis and essential thrombocythemia.
A 56-year-old brown-skinned man from São Paulo was
admitted to Hospital das Clínicas, the São Paulo Univer-
sity Medical School Hospital in January 2004, with ana-
sarca and ischemia of the fourth and fifth toes of his left
foot. The patient reported progressive increase of abdomi-
nal girth and lower extremities as well as facial edema for
5 months, and pain in and darker skin of the fourth and
fifth toes of his left foot over the previous 10 days. He also
reported hyporexia and a 18-kg body weight loss associ-
ated with dyspepsia, flatulence, and episodes of hiccups.
He had no complaints of urinary alterations, dyspnea, ab-
dominal pain, intermittent claudication, altered bowel hab-
its, or altered stool.
The patient also reported that he had been hypertensive
for 10 years and had made irregular use of propranolol. A
former smoker (from 14 to 32 years of age), he had aller-
gic rhinitis.
He had no history of diabetes, excessive alcohol con-
sumption, or blood transfusions.
On physical examination, his overall condition was
good, with normal colored mucosa; eupnea; body weight,
70 kg; heart rate, 80 beats/minute; and blood pressure, 150/
100 mm Hg. There was evidence of pleural effusion at the
base of the left lung, moderate ascites, moderate edema of
the lower extremities, and mild facial edema. The fourth
and fifth toes of his left foot were sore, with darker col-
oration (Fig. 1). His peripheral pulses were symmetric with
normal amplitudes.
Figure 1 - Gangrene of the left foot toes
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Aspirin, 300 mg/day, pentoxifylline 1,200 mg/day, and
analgesics were given, and the clinical condition was in-
vestigated. Laboratory tests showed severe
hypoalbuminemia (alb = 1.8 g/dL), dyslipidemia (total cho-
lesterol = 426 mg/dL, LDL = 347 mg/dL, HDL = 27 mg/
dL and triglycerides = 259 mg/dL), thrombocytosis (1.2
million platelets/mm3), and inflammatory activity (ESR =
85 mm/h, CRP = 66 mg/dL). Other results were: BUN =
39 mg/dL, creatinine = 1.5 mg/dL, hemoglobin = 12.2 mg/
dL, hematocrit = 39%, white-cell count = 8,750/mm3
(lymphocytes = 1,800/mm3, eosinophils = 100/mm3), se-
rum iron = 59 mg/dL, and serum ferritin = 326 mg/dL.
No intramural thrombi or myocardial dysfunction was
detected by Doppler echocardiogram. The electrocardio-
gram was normal, and a chest X-ray confirmed left pleu-
ral effusion.
Diuretics and simvastatin (40 mg/day) were adminis-
tered.
Nephrotic syndrome or liver failure were ruled out as
causes of hypoalbuminemia after measurement of 24-h pro-
teinuria (0.61 g and 0.78 g) and liver function (prothrombin
time = 85% and factor V activity = 100%). Hepatitis B and
C serological tests were negative. Fecal chromium-51–
labeled albumin revealed a relevant loss of 600 mL in 24
h (normal values < 14 mL in 24 h), confirming protein-
losing enteropathy as the diagnosis.
Once we had determined a protein-losing enteropathy,
its etiology was investigated. There was no evidence of
blood, fat, white blood cells, or parasites in the patient’s
feces. Serology for HIV, antinuclear antibodies, and
antiendomysial antibodies was negative. Serum
immunoglobulins were within normal ranges. Abdominal
computed tomography revealed moderate ascites and mild
hepatosplenomegaly. The ascitic and pleural liquids did not
exhibit the features of a transudate. A small benign gastric
ulcer with presence of Helicobacter pylori was revealed by
endoscopy with gastric biopsy. Colonoscopy was per-
formed, and 4 small tubulovillous polyps with high-grade
dysplasia were completely excised.
Contrast radiography revealed increased transit time of
the small intestine and nonspecific alterations in the mu-
cosa. Enteroscopy showed no alterations. Multiple duode-
nal and jejunal biopsies revealed a chronic nonspecific en-
teritis. Intestinal biopsies (small bowel and colon) were
negative by red-Congo stain.
Persistent thrombocytosis after improvement of the le-
sions in the patient’s toes and inflammatory activity mark-
ers led to cytogenetic analysis of the bone marrow, which
revealed large megakaryocytes and platelet debris. These
findings suggested essential thrombocythemia. Hydroxyu-
rea 1 g/day was administered to the patient.
The patient’s general condition worsened, with intense
asthenia, edema unresponsive to diuretics; the patient de-
veloped dyspnea and suddenly died. Necropsy did not re-
veal the cause of death, but histological study of the
gastrointestinal tract showed findings consistent with eosi-
nophilic gastroenteritis (Figure 2).
Protein-losing enteropathy is an unusual manifestation
of some diseases, particularly gastrointestinal disorders,
which may be associated with severe hypoalbuminemia. A
gastrointestinal disorder should be considered when the
regular causes of hypoalbuminemia such as malnutrition,
nephrotic syndrome, and chronic liver disease are ruled out.
Protein-losing enteropathy diagnostic studies consist of
measuring fecal ±1-antitrypsin or fecal chromium-51–
labeled albumin, and its main causes are ulcerative lesions
of the gastrointestinal tract, nonulcerative lesions in the
mucosa, and lymphatic diseases. In this case, diagnosis was
provided by scintigraphy, but the etiology was only re-
vealed at autopsy: findings of the detailed histological study
of the gastrointestinal tract were consistent with eosi-
nophilic gastroenteritis, a rare cause of enteric loss of pro-
tein.6
Eosinophilic gastroenteritis is a rare disease that typi-
cally manifests itself between the third and fifth decades
of life. It is slightly more prevalent in men. Its etiology is
unknown, and its pathogenesis poorly understood. Recent
data suggest that in this disorder, eosinophils may directly
damage the gastrointestinal tract wall by releasing gran-
ules containing cationic proteins and leukotrienes.7
Final diagnosis is provided by the following criteria:
presence of gastrointestinal symptoms, eosinophilic infil-
Figure 2 - Histological study of gastrointestinal tract. Note an abundant
eosinophilic infiltration of the mucosa layer and the presence of lymphocytes
in the corion. These findings are consistent with eosinophilic gastroenteritis
(HE - 200x)
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tration in 1 or more biopsied areas, absence of eosinophilic
involvement in other organs, and absence of a parasite in-
fection.
Approximately 50% of patients have a past or family
history of allergy (including atopy, asthma, or nasal pol-
yps) or history of food intolerance or food allergy. The
stomach and the small bowel are the most commonly in-
volved organs.
Pathophysiological and clinical classification of eosi-
nophilic gastroenteritis has been proposed according to the
layer of the gut wall mostly affected: mucosa, muscle layer,
or subserosal tissues.4 The most prevalent form affects mostly
the mucosal (and submucosal) layers, and its symptoms typi-
cally include colicky pain, nausea, vomiting, diarrhea, and
weight loss. Iron-deficiency anemia is common, and mal-
absorption syndrome may be present; protein-losing enter-
opathy may occur in 20% to 30% of cases.4,8 The muscle-
layer disease typically presents with pyloric or upper intes-
tinal obstruction, such as colicky abdominal pain, nausea,
and vomiting. It is associated with a thickened and rigid
bowel. The rarest form of eosinophilic gastroenteritis is the
serosal disease. It usually affects all layers of the bowel, and
patients may present eosinophilic ascites with serosal and
visceral peritoneal inflammation. The ascitic fluid is often
a sterile exudate with a high eosinophil count.
In this case, the ascitic fluid was a transudate, suggest-
ing that it was associated with severe hypoalbuminemia and
not with the disease itself. Although the association of pleu-
ral effusion with the disease is only reported in very few
cases,2 the pleural effusion of this patient should be asso-
ciated with his hypoalbuminemia.
The radiographic changes found in eosinophilic gastro-
enteritis vary and are not specific.9 The gastric and small
intestine folds can be thickened, with or without nodular
filling defects, and the small intestine may be also dilated.
Occasionally, the ileum resembles the jejunum because of
increased thickness of the ileal folds. These changes may
be absent in at least 40% of patients. Computed tomogra-
phy may reveal a thickened intestinal wall and localized
mesenteric lymphadenopathy, with serosal involvement and
with the presence of ascitic fluid.
Endoscopy examination may show a normal mucosa or
prominent mucosal folds, hyperemia, ulceration, and pres-
ence of nodules. Findings at laparoscopy vary from
hyperemia of the intestinal loops to a picture resembling
peritoneal carcinomatosis.
Upper GI endoscopy can show a normal mucosa or
prominent folds, hyperemia, ulceration, and nodules of the
gastrointestinal mucosa. Laparoscopy may show hyperemia
of bowel folds and a pattern similar to that of peritoneal
carcinomatosis.
Sometimes gastrointestinal mucosa biopsies reveal no
abnormality. In certain situations, laparoscopic-guided bi-
opsies are indicated to fully evaluate the thickness of the
bowel wall.10 Histological analyses reveal edema and an
inflammatory infiltrate consisting mainly of eosinophils
arranged in chains and fully infiltrated into the submucosal
layer. In this report, the gastric and intestinal biopsies did
not show any specific abnormality. Diagnosis of eosi-
nophilic gastroenteritis with essential thrombocytosis was
made only at necropsy when a large portion of the
gastrointestinal tract was carefully studied. There is no
curative strategy to treat eosinophilic gastroenteritis; how-
ever, prednisone can be used to control the inflammation
and suppress the episodes of disease attacks. The mainte-
nance dose of prednisone can prevent symptoms from ap-
pearing. Other corticosteroids are being investigated. Aza-
thioprine and other immune suppressors have been success-
fully used in some cases, but the side effects of these drugs
are frequently responsible for discontinuation of therapy.
As for the hematological findings of this disease, iron
deficiency anemia is frequent, and peripheral eosinophilia
is present in up to 80% of the cases. Nevertheless, platelet
abnormalities have not been described. In this case, eosi-
nophilia and iron deficiency anemia were not observed, in
contrast to the presence of severe thrombocytosis.
The elevated platelet count could be a reactive throm-
bocytosis to the inflammatory process in the patient’s foot
fingers, but the persistence of an elevated platelet count
(above 1 million per mm3) after improvement of the clini-
cal picture and a reduction of serum inflammatory marker
levels suggested essential thrombocythemia, a myelopro-
liferative disease. The presence of digital ischemia, a com-
mon manifestation of this disease, and the good response
to the use of an antiplatelet agent reinforced the hypotheti-
cal diagnosis. The presence of giant megakaryocytes and
platelet debris in the bone marrow are compatible with the
diagnosis of essential thrombocytosis.11 The patient’s age
was within the age range in which most cases are diagnosed
(50-60 years). The development of digital ischemia was
probably facilitated by risk factors related to atherosclero-
sis, such as dyslipidemia, hypertension, and smoking his-
tory. High-risk patients or those with a previous history of
vascular events such as cerebrovascular or digital ischemia
should receive aggressive platelet depletion therapy in or-
der to maintain platelet count below 500,000 per mm3. An-
other possible therapy is plateletpheresis, which can be used
to quickly reduce the platelet count and control the symp-
toms. A low dose of an antiplatelet agents can prevent
thrombotic events in the acute and subacute phases, but its
chronic use in asymptomatic patients has not yet been
evaluated.5 In the present case, the patient was initially
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treated with aspirin due to the acute thrombotic event.
Later, when the primary nature of the thrombocytosis had
been defined, hydroxyurea was administered.
Essential thrombocythemia is not the cause of protein-
losing enteropathy. The relationship between this disease
and eosinophilic gastroenteritis is not well understood. We
present a unique case of association between these two dis-
eases.
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